跳至主要内容
临床试验/KCT0002972
KCT0002972已完成未知

Comparison of intravascular ultrasound–guided vs. angiography-guided angioplasty and dual-antiplatelet v. triple-antiplatelet therapy for outcomes of drug-coated balloon in the treatment of femoropopliteal Artery disease (IVUS-DCB)

Yonsei University Health System, Severance Hospital0 个研究点目标入组 240 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 85(Year)(—)
性别
All

入选标准

  • 1) Age 19 years or older
  • 2) Symptomatic peripheral artery disease:
  • - Moderate or severe claudication (Rutherford category 2 or 3)
  • - Critical limb ischemia (Rutherford category 4 or 5)
  • 3) Femoropopliteal artery disease (stenosis > 50%)
  • 4) ABI <0.9
  • 5) Patients with signed informed consent

排除标准

  • 1) Acute critical limb ischemia
  • 2) Severe critical limb ischemia (Rutherford category 6)
  • 3) Known hypersensitivity or contraindication to any of the following medications: heparin, aspirin, clopidogrel, cilostazol, or contrast agents
  • 4) Patients requiring oral anticoagulation using warfarin or NOAC
  • 5) Age > 85 years
  • 6) Severe hepatic dysfunction (> 3 times normal reference values)
  • 7) Significant leucopenia, neutropenia, thrombocytopenia, anemia, or known bleeding diathesis
  • 8) LVEF < 40% or clinically overt congestive heart failure
  • 9) Pregnant women or women with potential childbearing
  • 10) Life expectancy <1 year due to comorbidity
  • 11) Previous bypass surgery or stenting in the target femoropopliteal artery
  • 12) Untreated inflow disease of the ipsilateral pelvic or femoropopliteal arteries (more than 50% stenosis or occlusion)

研究者

相似试验